Stacey M Polk

Stacey M. Polk serves as a key procurement professional responsible for managing complex acquisitions in scientific and analytical instrumentation, laboratory services, and research and development support. While her official title and agency are not specified, her contracting patterns indicate a central role in executing technical procurements that enable critical scientific operations, likely within a federal research, regulatory, or public health entity. She routinely handles competitive solicitations under FAR Part 15, with a strong emphasis on performance-based contracting and technical evaluation criteria for high-precision equipment and analytical services. Her contractor relationships center on manufacturers and service providers specializing in laboratory instrumentation, testing methodologies, and R&D support. She engages with a mix of large prime contractors and small businesses capable of delivering specialized analytical tools and scientific services, fostering partnerships that prioritize technical capability, quality assurance, and compliance with federal standards. Her procurement approach reflects a preference for open competition, with minimal reliance on set-asides, suggesting a focus on technical merit and market readiness over socioeconomic preferences. Polk’s set-aside preferences are overwhelmingly skewed toward unrestricted competitions, with only 5% of awards designated as total small business set-asides under FAR 19.5. This indicates a procurement strategy grounded in open market principles, where socioeconomic programs are used sparingly and only when market conditions or technical requirements justify them. Her approach aligns with agencies prioritizing technical excellence and broad vendor participation over targeted socioeconomic goals. Her primary NAICS focus lies in Analytical Laboratory Instrument Manufacturing (334516), reflecting deep expertise in procuring advanced scientific equipment such as chromatographs, spectrometers, and automated analyzers. She also consistently acquires testing laboratory services (541380) and R&D in physical and life sciences (541712), demonstrating domain knowledge in analytical chemistry, biopharmaceutical development, and quality control systems. Her work supports mission-critical scientific infrastructure requiring rigorous compliance and technical precision.